Riskpilot← Back to searchSign inGet full accessMedMike AB
ABActiveOrg 5591454896Strandgatan 13 B Lgh 1003Engineering activities and related technical consultancy · NACE 7112Est. 20181 employees
Revenue 2025
SEK 447K
-26% vs 2024
EBITDA margin
85.5%
-28% vs 2024
Equity ratio
36.7%
Financial strength
Net profit 2025
SEK 228K
-29% vs 2024
| Revenue | SEK 447K | -26% |
| EBITDA | SEK 382K | -28% |
| Net profit | SEK 228K | -29% |
| Total assets | SEK 825K | -17% |
| Equity | SEK 303K | -36% |
| Employees | 1 | — |
Legal name
MedMike AB
Org number
5591454896
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
17 januari 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Tjänster och utbildning inom hälso- och sjukvård framförallt i form av arbete som idrottsläkare och arbete som läkare inom primärvård. Teknisk konsultverksamhet inom bygg, fastighet och processindustri samt konsultverksamhet inom ekonomi avseende fastighetsvärdering och företagsvärdering.
Address
Strandgatan 13 B Lgh 1003
Email
mickejo123@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 193 | 390 | 508 | 601 | 447 |
| Staff expenses | — | — | −13 | −14 | −36 |
| EBITDA | 142 | 359 | 447 | 531 | 382 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 142 | 359 | 447 | 531 | 382 |
| Net financials | — | — | −0 | −1 | −3 |
| Profit before tax | 106 | 359 | 335 | 404 | 289 |
| Tax | −22 | −74 | −70 | −85 | −62 |
| Net profit | 84 | 285 | 265 | 319 | 228 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 478 | 697 | 768 | 996 | 825 |
| Equity | 311 | 471 | 356 | 475 | 303 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 56 | 116 | 190 | 172 | 84 |
| Total debt | 56 | 116 | 190 | 172 | 84 |
EBITDA margin
85.5%
This company
15.8%
Market median
+441% vs market
20212025
Equity ratio
36.7%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
75.2%
This company
18.4%
Market median
+309% vs market
20212025
Net profit margin
50.9%
This company
8.1%
Market median
+528% vs market
20212025
Asset turnover
0.54×
This company
1.12×
Market median
-52% vs market
20212025
Debt / equity
1.73×
This company
0.62×
Market median
-179% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedMike AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Mikael Jonsson | Chief Executive Officer | 0 companies |
| Jan Rikard Jonsson | Chairman | 0 companies |
| Jan Olof Mårten Jonsson | Board of Directors | 0 companies |
| Barbro Elisabeth Jonsson | Deputy Board Member | 0 companies |